Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir

Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir

A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decr...

Full description

Bibliographic Details
Main Authors: Yi-Hao Chan, Barnaby E. Young, Siew-Wai Fong, Ying Ding, Yun Shan Goh, Rhonda Sin-Ling Chee, Seow-Yen Tan, Shirin Kalimuddin, Paul A. Tambyah, Yee-Sin Leo, Lisa F. P. Ng, David Chien Lye, Laurent Renia
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
COVID-19
remdesivir (GS-5734)
T-cells
tissue repair
disease progression
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.680188/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.680188/full

Similar Items